Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma

European Respiratory Journal

Volumn 48, Issue 4, 2016, Pages 1052-1062

  Ilmarinen, Pinja ^a   Tuomisto, Leena E ^a   Niemelä, Onni ^a,b   Danielsson, Joanna ^a,b   Haanpää, Jussi ^a   Kankaanranta, Terhi ^c   Kankaanranta, Hannu ^a,b  

^a SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c Police University College   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; C REACTIVE PROTEIN; CORTICOSTEROID; HIGH SENSITIVITY C REACTIVE PROTEIN; INTERLEUKIN 6; UNCLASSIFIED DRUG; IL6 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DRUG MEGADOSE; EOSINOPHIL; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN CELL; INFLAMMATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; AGED; BLOOD; BREATHING; CHRONIC OBSTRUCTIVE LUNG DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; AGE OF ONSET; AGED; ASTHMA; C-REACTIVE PROTEIN; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; RESPIRATION; TREATMENT OUTCOME;

EID: 84990046735     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.02198-2015     Document Type: Article

References (45)

1. Bisgaard H, Bønnelykke K. Long-term studies of the natural history of asthma in childhood. J Allergy Clin Immunol 2010; 126: 187-197.
2. Ilmarinen P, Tuomisto LE, Kankaanranta H. Phenotypes, risk factors and mechanisms of adult-onset asthma. Mediators Inflamm 2015; 2015: 1-19.
3. Amelink M, de Nijs SB, de Groot JC, et al. Three phenotypes of adult-onset asthma. Allergy 2013; 68: 674-680.
4. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18: 716-725.
5. Tuomisto LE, Ilmarinen P, Kankaanranta H. Prognosis of new-onset asthma diagnosed at adult age. Respir Med 2015; 109: 944-954.
6. Gershon AS, Wang C, Guan J, et al. Burden of comorbidity in individuals with asthma. Thorax 2010; 65: 612-618.
7. Kankaanranta H, Kauppi P, Tuomisto LE, et al. Emerging comorbidities in adult asthma: risks, clinical associations and mechanisms. Mediators Inflamm 2016; 2016: 3690628.
8. Wijnhoven HA, Kriegsman DM, Hesselink AE, et al. The influence of comorbidity on health-related quality of life in asthma and COPD patients. Respir Med 2003; 97: 468-475.
9. Lavoie KL, Bacon SL, Barone S, et al. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both? Chest 2006; 130: 1039-1047.
10. Kapadia SG, Wei C, Bartlett SJ, et al. Obesity and symptoms of depression contribute independently to the poor asthma control of obesity. Respir Med 2014; 108: 1100-1107.
11. Jiang M, Qin P, Yang X. Comorbidity between depression and asthma via immune-inflammatory pathways: a meta-analysis. J Affect Disord 2014; 166: 22-29.
12. Esser N, Legrand-Poels S, Piette J, et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014; 105: 141-150.
13. Skeoch S, Bruce IN. Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol 2015; 11: 390-400.
14. Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull 2014; 140: 774-815.
15. Wood LG, Baines KJ, Fu J, et al. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 2012; 142: 86-93.
16. Fu JJ, Baines KJ, Wood LG, et al. Systemic inflammation is associated with differential gene expression and airway neutrophilia in asthma. OMICS 2013; 17: 187-199.
17. Kankaanranta H, Ilmarinen P, Kankaanranta T, et al. Seinajoki Adult Asthma Study (SAAS): a protocol for a 12-year real-life follow-up study of new-onset asthma diagnosed at adult age and treated in primary and specialised care. NPJ Prim Care Respir Med 2015; 25: 15042.
18. Global Initiative for Asthma (GINA), Global Initiative for Chronic Obstructive Lung Disease (GOLD). Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS). www.goldcopd.org/ Date last accessed: April, 2015. Date last updated: April, 2015.
19. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
20. American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930.
21. Barley EA, Quirk FH, Jones PW. Asthma health status measurement in clinical practice: validity of a new short and simple instrument. Respir Med 1998; 92: 1207-1214.
22. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. www.ginasthma. org/ Date last updated: 2010.
23. Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012; 380: 37-43.
24. Morjaria JB, Babu KS, Vijayanand P, et al. Sputum IL-6 concentrations in severe asthma and its relationship with FEV1. Thorax 2011; 66: 537.
25. Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol 2015; 16: 448-457.
26. Michaud M, Balardy L, Moulis G, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc 2013; 14: 877-882.
27. Rincon M, Irvin CG. Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci 2012; 8: 1281-1290.
28. Neveu WA, Allard JL, Raymond DM, et al. Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function. Respir Res 2010; 11: 28. 9921-11-28.
29. Zhang XL, Topley N, Ito T, et al. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. J Biol Chem 2005; 280: 12239-12245.
30. McKinley L, Alcorn JF, Peterson A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 2008; 181: 4089-4097.
31. Perttunen H, Moilanen E, Zhang X, et al. Beta2-agonists potentiate corticosteroid-induced neutrophil survival. COPD 2008; 5: 163-169.
32. Zhang X, Moilanen E, Adcock IM, et al. Divergent effect of mometasone on human eosinophil and neutrophil apoptosis. Life Sci 2002; 71: 1523-1534.
33. Ilmarinen P, Kankaanranta H. Eosinophil apoptosis as a therapeutic target in allergic asthma. Basic Clin Pharmacol Toxicol 2014; 114: 109-117.
34. Miller GE, Cohen S, Ritchey AK. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol 2002; 21: 531-541.
35. Rönmark E, Lindberg A, Watson L, et al. Outcome and severity of adult onset asthma: report from the obstructive lung disease in northern Sweden studies (OLIN). Respir Med 2007; 101: 2370-2377.
36. Konstantellou E, Papaioannou AI, Loukides S, et al. Persistent airflow obstruction in patients with asthma: characteristics of a distinct clinical phenotype. Respir Med 2015; 109: 1404-1409.
37. Adcock IM, Marwick J, Casolari P, et al. Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD). Curr Pharm Des 2010; 16: 3554-3573.
38. Sözener ZÇ, Aydin Ö, Mungan D, et al. Prognosis of adult asthma: a 7-year follow-up study. Ann Allergy Asthma Immunol 2015; 114: 370-373.
39. Gershon AS, Guan J, Wang C, et al. Describing and quantifying asthma comorbidity: a population study. PLoS One 2012; 7: e34967.
40. Steppuhn H, Langen U, Keil T, et al. Chronic disease comorbidity of asthma and unscheduled asthma care among adults: results of the national telephone health interview survey German Health Update (GEDA) 2009 and 2010. Prim Care Respir J 2014; 23: 22-29.
41. Lessard A, Turcotte H, Cormier Y, et al. Obesity and asthma: a specific phenotype? Chest 2008; 134: 317-323.
42. Christiansen SC, Schatz M, Yang SJ, et al. Hypertension and Asthma: A Comorbid Relationship. J Allergy Clin Immunol Pract 2016; 4: 76-81.
43. Ban GY, Ye YM, Lee Y, et al. Predictors of asthma control by stepwise treatment in elderly asthmatic patients. J Korean Med Sci 2015; 30: 1042-1047.
44. Fu JJ, McDonald VM, Gibson PG, et al. Systemic Inflammation in Older Adults With Asthma-COPD Overlap Syndrome. Allergy Asthma Immunol Res 2014; 6: 316-324.
45. França-Pinto A, Mendes FA, de Carvalho-Pinto RM, et al. Aerobic training decreases bronchial hyperresponsiveness and systemic inflammation in patients with moderate or severe asthma: a randomised controlled trial. Thorax 2015; 70: 732-739.